Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 90

1.

The efficacy of smartphone-based mental health interventions for depressive symptoms: a meta-analysis of randomized controlled trials.

Firth J, Torous J, Nicholas J, Carney R, Pratap A, Rosenbaum S, Sarris J.

World Psychiatry. 2017 Oct;16(3):287-298. doi: 10.1002/wps.20472.

2.

Ziziphus spinosa seeds for insomnia: A review of chemistry and psychopharmacology.

Shergis JL, Ni X, Sarris J, Zhang AL, Guo X, Xue CC, Lu C, Hugel H.

Phytomedicine. 2017 Oct 15;34:38-43. doi: 10.1016/j.phymed.2017.07.004. Epub 2017 Jul 4. Review.

PMID:
28899507
3.

A Review of the Conceptualisation and Risk Factors Associated with Treatment-Resistant Depression.

Murphy JA, Sarris J, Byrne GJ.

Depress Res Treat. 2017;2017:4176825. doi: 10.1155/2017/4176825. Epub 2017 Aug 3. Review.

4.

The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis - CORRIGENDUM.

Firth J, Stubbs B, Sarris J, Rosenbaum S, Teasdale S, Berk M, Yung AR.

Psychol Med. 2017 Jul 17:1. doi: 10.1017/S0033291717001866. [Epub ahead of print] No abstract available.

PMID:
28712367
5.

Erythrocyte polyunsaturated fatty acid composition is associated with depression and FADS genotype in Caucasians.

Cribb L, Murphy J, Froud A, Oliver G, Bousman CA, Ng CH, Sarris J.

Nutr Neurosci. 2017 May 29:1-13. doi: 10.1080/1028415X.2017.1327685. [Epub ahead of print]

PMID:
28552045
6.

Can smartphone mental health interventions reduce symptoms of anxiety? A meta-analysis of randomized controlled trials.

Firth J, Torous J, Nicholas J, Carney R, Rosenbaum S, Sarris J.

J Affect Disord. 2017 Aug 15;218:15-22. doi: 10.1016/j.jad.2017.04.046. Epub 2017 Apr 25. Review.

7.

Adjunctive low-dose docosahexaenoic acid (DHA) for major depression: An open-label pilot trial.

Smith DJ, Sarris J, Dowling N, O'Connor M, Ng CH.

Nutr Neurosci. 2017 Feb 22:1-5. doi: 10.1080/1028415X.2017.1283128. [Epub ahead of print]

PMID:
28224818
8.

Exploring the Effect of Lactium™ and Zizyphus Complex on Sleep Quality: A Double-Blind, Randomized Placebo-Controlled Trial.

Scholey A, Benson S, Gibbs A, Perry N, Sarris J, Murray G.

Nutrients. 2017 Feb 17;9(2). pii: E154. doi: 10.3390/nu9020154.

9.

The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis.

Firth J, Stubbs B, Sarris J, Rosenbaum S, Teasdale S, Berk M, Yung AR.

Psychol Med. 2017 Jul;47(9):1515-1527. doi: 10.1017/S0033291717000022. Epub 2017 Feb 16.

PMID:
28202095
10.

Clinical use of nutraceuticals in the adjunctive treatment of depression in mood disorders.

Sarris J.

Australas Psychiatry. 2017 Aug;25(4):369-372. doi: 10.1177/1039856216689533. Epub 2017 Jan 31.

PMID:
28135835
11.

Polyunsaturated fatty acids and suicide risk in mood disorders: A systematic review.

Pompili M, Longo L, Dominici G, Serafini G, Lamis DA, Sarris J, Amore M, Girardi P.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Mar 6;74:43-56. doi: 10.1016/j.pnpbp.2016.11.007. Epub 2016 Dec 8. Review.

PMID:
27940200
13.

N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms.

Rossell SL, Francis PS, Galletly C, Harris A, Siskind D, Berk M, Bozaoglu K, Dark F, Dean O, Liu D, Meyer D, Neill E, Phillipou A, Sarris J, Castle DJ.

BMC Psychiatry. 2016 Sep 15;16(1):320. doi: 10.1186/s12888-016-1030-3.

14.

Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses.

Sarris J, Murphy J, Mischoulon D, Papakostas GI, Fava M, Berk M, Ng CH.

Am J Psychiatry. 2016 Jun 1;173(6):575-87. doi: 10.1176/appi.ajp.2016.15091228. Epub 2016 Apr 26. Review.

PMID:
27113121
15.

A Prospective Study of Serotonin and Norepinephrine Transporter Genes and the Response to Desvenlafaxine Over 8 Weeks in Major Depressive Disorder.

Ng CH, Bousman C, Smith DJ, Dowling N, Byron K, King J, Sarris J.

Pharmacopsychiatry. 2016 Sep;49(5):210-212. Epub 2016 Mar 29.

PMID:
27023264
16.

Herbal medicine use behaviour in Australian adults who experience anxiety: a descriptive study.

McIntyre E, Saliba AJ, Wiener KK, Sarris J.

BMC Complement Altern Med. 2016 Feb 11;16:60. doi: 10.1186/s12906-016-1022-3.

17.

A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831).

Kean JD, Kaufman J, Lomas J, Goh A, White D, Simpson D, Scholey A, Singh H, Sarris J, Zangara A, Stough C.

Nutrients. 2015 Dec 2;7(12):9931-45. doi: 10.3390/nu7125507.

18.

Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial.

Savage KM, Stough CK, Byrne GJ, Scholey A, Bousman C, Murphy J, Macdonald P, Suo C, Hughes M, Thomas S, Teschke R, Xing C, Sarris J.

Trials. 2015 Nov 2;16:493. doi: 10.1186/s13063-015-0986-5.

19.

International Society for Nutritional Psychiatry Research consensus position statement: nutritional medicine in modern psychiatry.

Sarris J, Logan AC, Akbaraly TN, Paul Amminger G, Balanzá-Martínez V, Freeman MP, Hibbeln J, Matsuoka Y, Mischoulon D, Mizoue T, Nanri A, Nishi D, Parletta N, Ramsey D, Rucklidge JJ, Sanchez-Villegas A, Scholey A, Su KP, Jacka FN.

World Psychiatry. 2015 Oct;14(3):370-1. doi: 10.1002/wps.20223. No abstract available.

20.

Implementation of psychiatric-focused lifestyle medicine programs in Asia.

Sarris J, Nishi D, Xiang YT, Su KP, Bannatyne A, Oliver G, Kua EH, Ng CH.

Asia Pac Psychiatry. 2015 Dec;7(4):345-54. doi: 10.1111/appy.12212. Epub 2015 Sep 25. Review.

PMID:
26403310

Supplemental Content

Loading ...
Support Center